Literature DB >> 2049229

Inhibition of the metabolism of paracetamol by isoniazid.

M M Epstein1, S D Nelson, J T Slattery, T F Kalhorn, R A Wall, J M Wright.   

Abstract

1. The effect of isoniazid given daily for 7 days on paracetamol (acetaminophen) kinetics and metabolism was studied in 10 healthy volunteers. Paracetamol, 500 mg, was given before isoniazid, on day 7 of isoniazid administration, and 2 days after the last dose of isoniazid. 2. On day 7, isoniazid markedly inhibited the formation clearance of the glutathione and catechol metabolites by 69.7% and 62.2%, respectively. Total paracetamol clearance was lowered by 15.2%. There was no effect of isoniazid on the non-oxidative pathways of paracetamol elimination. 3. Two days after isoniazid was discontinued, paracetamol metabolism had returned to pre-isoniazid values.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049229      PMCID: PMC1368379          DOI: 10.1111/j.1365-2125.1991.tb05501.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning?

Authors:  J A Critchley; E H Dyson; A W Scott; D R Jarvie; L F Prescott
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

Review 2.  Paracetamol overdosage. Pharmacological considerations and clinical management.

Authors:  L F Prescott
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

3.  Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs; D R Abernethy; M Knüchel
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

4.  Mechanism of the inhibitory action of isoniazid on microsomal drug metabolism.

Authors:  S F Muakkassah; W R Bidlack; W C Yang
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

5.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen.

Authors:  D C Dahlin; G T Miwa; A Y Lu; S D Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

Review 6.  Acetaminophen hepatotoxicity.

Authors:  M Black
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

7.  Analysis of acetaminophen metabolites in urine by high-performance liquid chromatography with UV and amperometric detection.

Authors:  J M Wilson; J T Slattery; A J Forte; S D Nelson
Journal:  J Chromatogr       Date:  1982-02-12

8.  Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.

Authors:  M C Mitchell; S Schenker; K V Speeg
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

9.  Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen.

Authors:  E T Morgan; D R Koop; M J Coon
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

10.  Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity.

Authors:  E Albano; M Rundgren; P J Harvison; S D Nelson; P Moldéus
Journal:  Mol Pharmacol       Date:  1985-09       Impact factor: 4.436

View more
  6 in total

1.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

Review 2.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

3.  PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.

Authors:  Ankit Balhara; Saranjit Singh
Journal:  Pharm Res       Date:  2021-09-13       Impact factor: 4.200

4.  Isoniazid hepatotoxicity: progress in understanding the immunologic component.

Authors:  Laura James; Dean Roberts
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

Review 5.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

6.  Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen.

Authors:  Sibo Jiang; Valvanera Vozmediano; Susan M Abdel-Rahman; Stephan Schmidt; Laura P James
Journal:  J Clin Pharmacol       Date:  2019-05-17       Impact factor: 3.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.